Check out our TEVA stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Teva Pharmaceutical Industries Ltd. ADR advanced stock charts by Barron's. View TEVA historical stock data and compare to other stocks, and exchanges.

Teva's transformation boosts profit growth and specialty drugs, offering an undervalued opportunity. Click here to read my ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

On the other hand, Goldman Sachs analysts see modest growth in the generics sector over the upcoming years. Although Teva’s growing portfolio of biosimilars—five more are anticipated to be ...

Teva sees return to growth after opioid settlement, shares jump By Steven Scheer July 27, 202210:39 AM PDTUpdated July 27, 2022 ...

Teva Pharmaceutical Industries TEVA reported second-quarter 2025 adjusted earnings of 66 cents per share, which beat the ...

Teva Pharmaceutical announces new growth strategy built on biosimilars, innovation By Eleanor Laise Follow Published: May 18, 2023, 9:05 a.m. ET ...

Teva expects to generate over $5 billion in innovative medicines revenue by 2030, with Austedo, Ajovy, and Uzedy driving growth. The company aims for a 30% operating margin and more than $3.5 ...

Nearly 10% of Teva staff in Israel called to reserve duty Q3 EPS $0.60 vs $0.59 yr earlier Q3 revenue up 7% to $3.9 billion Raises 2023 revenue estimate to $15.1-$15.5 billion Net debt falls below ...

Check out our TEVA stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.